StratDeck

Two stocks in Healthcare

Regeneron Pharmaceuticals vs Thermo Fisher Scientific: profit, growth, debt and price compared

Regeneron Pharmaceuticals is stronger on 6 of 7 figures: profit margin, sales growth, debt, price for its expected profit, dividend and price trend. Thermo Fisher Scientific is stronger on 1: analysts' view.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Regeneron Pharmaceuticals' storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Regeneron Pharmaceuticals and Thermo Fisher Scientific side by side
Regeneron PharmaceuticalsREGNThermo Fisher ScientificTMO
Net marginStronger: 28.5%14.9%
Revenue growth, past yearStronger: +36.27%+9.13%
Debt to equityStronger: 8.1%75.4%
Forward P/EStronger: 13.3×24.9×
Dividend yieldStronger: 0.39%0.27%
AnalystsBuy · 27Stronger: Strong buy · 25
From its 200-day averageStronger: +24.2%+17.3%

Share price over the past year

  • Regeneron Pharmaceuticals+30.4%
  • Thermo Fisher Scientific+20.3%

18 Nov 202518 Nov 2026

Regeneron Pharmaceuticals or Thermo Fisher Scientific: which is stronger?

  • REGN

    Which is more profitable?

    Regeneron Pharmaceuticals keeps more of each sale as profit: 28.5% against 14.9%.

  • REGN

    Which is growing its sales faster?

    Regeneron Pharmaceuticals is growing its sales faster: +36.27% over the past year, against +9.13%.

  • REGN

    Which has borrowed less?

    Regeneron Pharmaceuticals has borrowed less: its debt is 8.1% of what its shareholders own, against 75.4% for Thermo Fisher Scientific.

  • REGN

    Which costs less for the profit it is expected to make?

    Regeneron Pharmaceuticals costs less for the profit it is expected to make: 13.3× its forward earnings, against 24.9×.

  • REGN

    Which pays more in dividends?

    Regeneron Pharmaceuticals pays more back in dividends for what a share costs: 0.39% a year, against 0.27%.

  • TMO

    Which do analysts rate higher?

    Analysts are warmer on Thermo Fisher Scientific: Strong buy, against Buy for Regeneron Pharmaceuticals.

  • REGN

    Which is in the stronger price trend?

    Regeneron Pharmaceuticals' price is in the stronger trend: 24.2% above its 200-day average, against 17.3% above.

What each company does

REGNRegeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide.

Reports results on 28 January 2027

TMOThermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally.

Reports results on 28 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.